Key result
Diepoxide-treated bovine jugular vein conduits showed improved integration, endothelialization, and lack of mineralization compared to glutaraldehyde-treated conduits in a porcine model.
Why the study?
The widely used glutaraldehyde-preserved Contegra conduit has several drawbacks, prompting the investigation of diepoxide as an alternative preservation compound to improve conduit performance.
Does diepoxide treatment of bovine jugular vein conduits improve morphological properties and integration compared to glutaraldehyde treatment in a porcine model?
Does diepoxide treatment of bovine jugular vein conduits improve morphological properties and integration compared to glutaraldehyde treatment in a porcine model?
Answers are grounded in this paper and cite their sources.
Diepoxide treatment of bovine jugular vein conduits improves tissue integration and prevents mineralization compared to standard glutaraldehyde treatment in a porcine model.
Valved conduits are often required to replace pulmonary arteries (PA). A widely used Contegra device is made of bovine jugular vein (BJV), preserved with glutaraldehyde (GA) and iso-propanol. However, it has several drawbacks that may be attributed to its chemical treatment. We hypothesized that the use of an alternative preservation compound may significantly improve BJV conduit performance. This study aimed to compare the macroscopic and microscopic properties of the BJV treated with diepoxide (DE) and GA in a porcine model. Twelve DE-BJVs and four Contegra conduits were used for PA replacement in minipigs. To assess the isolated influence of GA, we included an additional control group-BJV treated with 0.625% GA (n = 4). The animals were withdrawn after 6 months of follow-up and the conduits were examined. Explanted DE-BJV had a soft elastic wall with no signs of thrombosis or calcification and good conduit integration, including myofibroblast germination, an ingrowth of soft connective tissue formations and remarkable neoangiogenesis. The inner surface of DE-BJVs was covered by a thin neointimal layer with a solid endothelium. Contegra grafts had a stiffer wall with thrombosis on the leaflets. Calcified foci, chondroid metaplasia, and hyalinosis were observed within the wall. The distal anastomotic sites had hyperplastic neointima, partially covered with the endothelium. The wall of GA-BJV was stiff and rigid with degenerative changes, a substantial amount of calcium deposits and dense fibrotic formations in adventitia. An irregular neointimal layer was presented in the anastomotic sites without endothelial cover in the GA BJV wall. These results demonstrate that DE treatment improves conduit integration and the endothelialization of the inner surface while preventing the mineralization of the BJV, which may reduce the risk of early conduit dysfunction.
No takes yet. Share an insight, caveat, or question.
Nichay et al. (2023) studied Pulmonary artery replacement (animal model) (n=20). Diepoxide (DE) treated bovine jugular vein (BJV) conduit vs. Contegra conduits and 0.625% glutaraldehyde-treated BJV was evaluated on Macroscopic and microscopic properties (morphological changes). Diepoxide-treated bovine jugular vein conduits showed improved integration, endothelialization, and lack of mineralization compared to glutaraldehyde-treated conduits in a porcine model.
Synapse has enriched 10 related papers. Consider them for comparative context: